Balance Sheet Belite Bio, Inc

Stocks

BLTE

US07782B1044

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 17:34:26 11/06/2026 BST			5-day change	1st Jan Change
140.23 ^USD	+2.64%		-4.54%	-13.79%

06-08	Belite Bio, Inc Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 04:00 PM
05-26	Mizuho Adjusts Price Target on Belite Bio to $215 From $223, Maintains Outperform Rating	MT

8670deb.poC1WKohg5xWAxh8Z2uiorJx1RqW-WqLTIoVckl1R8g.yOL-MedI-f0ZdH8WDAaX54ZGpV2jgALhK-NBMzoPc7Ke-fc27ETO9w5PKA

Published financial data: BELITE BIO, INC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	2.38M	3.95M	6.82M	10.06M	38.83M
R&D Expenses	7.42M	8.87M	24.84M	29.94M	45.38M
Other Operating Expenses, Total	9.8M	12.82M	31.67M	40M	84.21M
Operating Income	-9.8M	-12.82M	-31.67M	-40M	-84.21M
Interest Expense, Total	-	-16K	-25K	-20K	-2K
Interest And Investment Income	5K	23K	74K	3.74M	6.64M
Net Interest Expenses	5K	7K	49K	3.72M	6.64M
Currency Exchange Gains (Loss)	126K	166K	-4K	141K	-
Other Non Operating Income (Expenses)	-	-	-	-	-41K
EBT, Excl. Unusual Items	-9.67M	-12.65M	-31.62M	-36.14M	-77.61M
EBT, Incl. Unusual Items	-9.67M	-12.65M	-31.62M	-36.14M	-77.61M
Income Tax Expense	-	-	9K	6K	-
Earnings From Continuing Operations	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M
Net Income to Company	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M
Net Income - (IS)	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M
Net Income to Common Incl Extra Items	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M
Net Income to Common Excl. Extra Items	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M
Per Share Items
Net EPS - Basic	-1.01	-0.63	-1.19	-1.18	-2.31
Basic EPS - Continuing Operations	-1.01	-0.63	-1.19	-1.18	-2.31
Basic Weighted Average Shares Outstanding	9.57M	19.98M	26.59M	30.54M	33.54M
Net EPS - Diluted	-1.01	-0.63	-1.19	-1.18	-2.31
Diluted EPS - Continuing Operations	-1.01	-0.63	-1.19	-1.18	-2.31
Diluted Weighted Average Shares Outstanding	9.57M	19.98M	26.59M	30.54M	33.54M
Normalized Basic EPS	-0.63	-0.4	-0.74	-0.74	-1.45
Normalized Diluted EPS	-0.63	-0.4	-0.74	-0.74	-1.45
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-9.77M	-12.76M	-31.53M	-39.83M	-84.02M
EBITA	-9.8M	-12.82M	-31.67M	-39.99M	-84.2M
EBIT	-9.8M	-12.82M	-31.67M	-40M	-84.21M
EBITDAR	-	-	-	-39.51M	-83.68M
Effective Tax Rate - (Ratio)	-	-	-0.03	-0.02	-
Total Current Taxes	-	-	-	6K	-
Normalized Net Income	-6.04M	-7.9M	-19.76M	-22.59M	-48.51M
Supplemental Operating Expense Items
General and Administrative Expenses	2.38M	3.95M	6.82M	10.06M	-
Research And Development Expense From Footnotes	7.42M	8.87M	24.84M	29.94M	45.38M
Net Rental Expense, Total	-	-	-	316K	341K
Imputed Operating Lease Interest Expense	-	-	-	71.06K	11.29K
Imputed Operating Lease Depreciation	-	-	-	245K	330K
Stock-Based Comp., R&D Exp. (Total)	52K	818K	1.72M	3.78M	9.15M
Stock-Based Comp., G&A Exp. (Total)	1.48M	665K	2.11M	5.21M	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	29.77M
Total Stock-Based Compensation	1.53M	1.48M	3.82M	8.99M	38.92M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	17.34M	42.09M	88.16M	31.68M	353M
Short Term Investments	-	-	-	113M	139M
Total Cash And Short Term Investments	17.34M	42.09M	88.16M	145M	492M
Other Receivables	-	2K	836K	575K	700K
Total Receivables	-	2K	836K	575K	700K
Prepaid Expenses	64K	699K	916K	1.33M	1.13M
Other Current Assets, Total	23K	17K	31K	19K	23K
Total Current Assets	17.43M	42.81M	89.94M	147M	494M
Gross Property Plant And Equipment	141K	1.57M	1.48M	1.31M	1.28M
Accumulated Depreciation	-47K	-225K	-183K	-341K	-507K
Net Property Plant And Equipment	94K	1.35M	1.3M	965K	777K
Long-term Investments	-	-	-	-	280M
Other Intangibles, Total	-	-	-	31K	19K
Deferred Charges Long-Term	815K	-	-	-	-
Other Long-Term Assets, Total	8K	119K	3.4M	4.06M	5.32M
Total Assets	18.35M	44.27M	94.64M	152M	781M
Liabilities
Accrued Expenses, Total	1.48M	1.83M	3.18M	5.47M	7.31M
Current Portion of Leases	-	198K	308K	276K	241K
Other Current Liabilities	151K	74K	149K	302K	2.33M
Total Current Liabilities	1.64M	2.1M	3.63M	6.05M	9.88M
Long-Term Leases	-	668K	578K	261K	188K
Total Liabilities	1.64M	2.77M	4.21M	6.31M	10.07M
Preferred Stock Convertible	31.81M	-	-	-	-
Total Preferred Equity	31.81M	-	-	-	-
Common Stock, Total	1K	3K	3K	3K	4K
Additional Paid In Capital	12.32M	81.76M	162M	254M	956M
Retained Earnings	-27.22M	-39.87M	-71.5M	-108M	-185M
Comprehensive Income and Other	-196K	-392K	-374K	-660K	-536K
Total Common Equity	-15.09M	41.5M	90.43M	146M	770M
Total Equity	16.71M	41.5M	90.43M	146M	770M
Total Liabilities And Equity	18.35M	44.27M	94.64M	152M	781M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.27M	24.9M	29.15M	31.83M	39.34M
ECS Total Common Shares Outstanding	10.27M	24.9M	29.15M	31.83M	39.34M
Book Value / Share	-1.47	1.67	3.1	4.58	19.59
Tangible Book Value	-15.09M	41.5M	90.43M	146M	770M
Tangible Book Value Per Share	-1.47	1.67	3.1	4.58	19.58
Total Debt	0	866K	886K	537K	429K
Net Debt	-17.34M	-41.22M	-87.27M	-145M	-492M
Debt Equivalent Oper. Leases	-	-	-	2.53M	2.73M
Account Code - Inventory Valuation	3	3	3	-	3
Machinery, Total	141K	445K	486K	598K	664K
Full Time Employees	12	16	20	25	41

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M
Depreciation & Amortization - CF	30K	198K	399K	445K	172K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	4K	12K
Depreciation & Amortization, Total	30K	198K	399K	449K	184K
(Gain) Loss From Sale Of Asset	-8K	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-49K	-
Stock-Based Compensation (CF)	1.53M	1.48M	3.82M	8.99M	38.92M
Other Operating Activities, Total	-	-	-	-3.61M	-1.03M
Change In Accounts Receivable	-	-32K	-16K	18K	-
Change In Accounts Payable	45K	-41K	-	13K	-8K
Change in Other Net Operating Assets	595K	-418K	-2.41M	1.1M	2.56M
Cash from Operations	-7.47M	-11.46M	-29.84M	-29.23M	-36.99M
Capital Expenditure	-74K	-394K	-63K	-116K	-178K
Sale of Property, Plant, and Equipment	18K	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-35K	-
Investment in Marketable and Equity Securities, Total	-	-	-	-110M	-305M
Cash from Investing	-56K	-394K	-63K	-111M	-305M
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	232K	37.99M	77.19M	58.2M	140M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-815K	-1.03M	-1.23M	25.39M	523M
Cash from Financing	-583K	36.96M	75.96M	83.6M	663M
Foreign Exchange Rate Adjustments	-161K	-366K	9K	-269K	117K
Net Change in Cash	-8.27M	24.74M	46.07M	-56.48M	321M
Supplemental Items
Cash Interest Paid	-	16K	-	-	1K
Cash Income Tax Paid (Refund)	-	-	-	6K	-
Levered Free Cash Flow	-4.01M	-7.1M	-15.3M	-13.42M	-9.77M
Unlevered Free Cash Flow	-4.01M	-7.09M	-15.28M	-13.4M	-9.76M
Change In Net Working Capital	-626K	360K	-354K	-2.31M	-3.94M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-27.78	-25.59	-28.5	-20.26	-11.29
Return on Total Capital	-29.52	-27.13	-29.61	-21.04	-11.48
Return On Equity %	-46.6	-43.45	-47.95	-30.6	-16.94
Return on Common Equity	87.36	-95.79	-47.95	-30.6	-16.94
Short Term Liquidity
Current Ratio	10.66	20.35	24.76	24.31	50.02
Quick Ratio	10.61	20.01	24.5	24.09	49.9
Operating Cash Flow to Current Liabilities	-4.57	-5.45	-8.21	-4.83	-3.74
Long Term Solvency
Total Debt/Equity	-	2.09	0.98	0.37	0.06
Total Debt / Total Capital	-	2.04	0.97	0.37	0.06
LT Debt/Equity	-	1.61	0.64	0.18	0.02
Long-Term Debt / Total Capital	-	1.58	0.63	0.18	0.02
Total Liabilities / Total Assets	8.91	6.26	4.45	4.15	1.29
EBIT / Interest Expense	-	-801.31	-1.27K	-2K	-42.1K
EBITDA / Interest Expense	-	-797.31	-1.26K	-1.98K	-41.84K
(EBITDA - Capex) / Interest Expense	-	-821.94	-1.26K	-1.98K	-41.93K
Total Debt / EBITDA	-	-0.07	-0.03	-0.01	-0.01
Net Debt / EBITDA	1.78	3.23	2.77	3.66	5.88
Total Debt / (EBITDA - Capex)	-	-0.07	-0.03	-0.01	-0.01
Net Debt / (EBITDA - Capex)	1.76	3.13	2.76	3.65	5.87
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	70.57	30.61	147.15	26.32	110.97
EBITA, 1 Yr. Growth %	70.59	30.87	147	26.29	110.53
EBIT, 1 Yr. Growth %	70.59	30.87	147	26.3	110.54
Earnings From Cont. Operations, 1 Yr. Growth %	68.02	30.85	150.09	14.26	114.73
Net Income, 1 Yr. Growth %	68.02	30.85	150.09	14.26	114.73
Normalized Net Income, 1 Yr. Growth %	68.05	30.85	150.02	14.28	114.76
Diluted EPS Before Extra, 1 Yr. Growth %	54.33	-37.32	87.87	-0.5	95.52
Net Property, Plant and Equip., 1 Yr. Growth %	104.35	1.33K	-3.42	-25.83	-19.48
Total Assets, 1 Yr. Growth %	-28.72	141.3	113.77	60.74	413.08
Tangible Book Value, 1 Yr. Growth %	114.48	-374.97	117.9	61.22	428.48
Common Equity, 1 Yr. Growth %	114.48	-374.97	117.9	61.25	428.38
Cash From Operations, 1 Yr. Growth %	68.26	53.3	160.4	-2.02	26.52
Capital Expenditures, 1 Yr. Growth %	270	432.43	-84.01	84.13	53.45
Levered Free Cash Flow, 1 Yr. Growth %	-	76.91	115.54	-12.28	-28.71
Unlevered Free Cash Flow, 1 Yr. Growth %	-	76.66	115.63	-12.27	-28.65
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	49.26	79.67	76.69	63.25
EBITA, 2 Yr. CAGR %	-	49.41	79.79	76.61	63.06
EBIT, 2 Yr. CAGR %	-	49.41	79.79	76.62	63.07
Earnings From Cont. Operations, 2 Yr. CAGR %	-	48.27	80.9	69.05	56.64
Net Income, 2 Yr. CAGR %	-	48.27	80.9	69.05	56.64
Normalized Net Income, 2 Yr. CAGR %	-	48.29	80.87	69.03	56.66
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-1.64	8.52	36.72	39.48
Net Property, Plant and Equip., 2 Yr. CAGR %	-	441.13	272.03	-15.36	-22.72
Total Assets, 2 Yr. CAGR %	-	31.15	127.12	85.37	187.18
Tangible Book Value, 2 Yr. CAGR %	-	142.85	144.78	87.43	191.89
Common Equity, 2 Yr. CAGR %	-	142.85	144.78	87.45	191.89
Cash From Operations, 2 Yr. CAGR %	-	60.61	99.8	59.73	11.34
Capital Expenditures, 2 Yr. CAGR %	-	343.85	-7.73	-45.74	68.09
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	95.27	37.5	-20.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	95.17	37.54	-20.73
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	76.58	59.76	87.45
EBITA, 3 Yr. CAGR %	-	-	76.67	59.82	87.26
EBIT, 3 Yr. CAGR %	-	-	76.67	59.82	87.27
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	76.5	55.21	83.08
Net Income, 3 Yr. CAGR %	-	-	76.5	55.21	83.08
Normalized Net Income, 3 Yr. CAGR %	-	-	76.49	55.2	83.08
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	22.04	5.43	54.04
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	204.68	117.34	-16.76
Total Assets, 3 Yr. CAGR %	-	-	54.34	102.4	160.27
Tangible Book Value, 3 Yr. CAGR %	-	-	134.23	112.97	164.79
Common Equity, 3 Yr. CAGR %	-	-	134.23	112.98	164.79
Cash From Operations, 3 Yr. CAGR %	-	-	88.68	57.56	47.79
Capital Expenditures, 3 Yr. CAGR %	-	-	46.59	16.16	-23.27
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	49.55	11.23
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	49.51	11.28
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	71.12
EBITA, 5 Yr. CAGR %	-	-	-	-	71.09
EBIT, 5 Yr. CAGR %	-	-	-	-	71.1
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	68.27
Net Income, 5 Yr. CAGR %	-	-	-	-	68.27
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	68.28
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	28.74
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	76.01
Total Assets, 5 Yr. CAGR %	-	-	-	-	97.86
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	155.78
Common Equity, 5 Yr. CAGR %	-	-	-	-	155.79
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	52.79
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	54.84